Tazidime and Emend drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tazidime (ceftazidime) and Emend (aprepitant). Common drug interactions include toxic skin eruption among females and angioedema among males.

The phase IV clinical study analyzes what interactions people have when they take Tazidime and Emend. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

What is Emend?

Emend has active ingredients of aprepitant. It is often used in nausea. eHealthMe is studying from 13,741 Emend users. Check the latest studies of Emend.

On Jul, 08, 2026

24 people who take Tazidime and Emend together, and have interactions are studied.

What are the common drug interactions of Tazidime and Emend, by gender? *:

female:

Toxic skin eruption (skin breakdown due to toxic substance)
Febrile neutropenia (fever with reduced white blood cells)
Nephritic syndrome (a collection of signs (known as a syndrome) associated with disorders affecting the kidneys, more specifically glomerular disorders)
Pulmonary alveolar haemorrhage (acute bleeding)
Septic shock (shock due to blood infection)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Erythema (redness of the skin)

male:

Angioedema (rapid swelling of the dermis)
Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Hypersensitivity
Oedema mouth (swelling of mouth)
Oral pain
Stomatitis (inflammation of mucous membrane of mouth)
Abdominal pain
Atypical pneumonia (acute respiratory disease marked by high fever and coughing)

What are the common drug interactions of Tazidime and Emend, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Febrile neutropenia (fever with reduced white blood cells)
Neuropathy peripheral (surface nerve damage)
Stomatitis (inflammation of mucous membrane of mouth)
Vocal cord paralysis

10-19:

Angioedema (rapid swelling of the dermis)
Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Hypersensitivity
Oedema mouth (swelling of mouth)
Oral pain
Stomatitis (inflammation of mucous membrane of mouth)
Drug clearance decreased
Drug level increased
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

20-29:

Febrile neutropenia (fever with reduced white blood cells)

30-39:

Nephritic syndrome (a collection of signs (known as a syndrome) associated with disorders affecting the kidneys, more specifically glomerular disorders)
Pulmonary alveolar haemorrhage (acute bleeding)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
Intestinal obstruction
Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)
Abdominal pain
Atypical pneumonia (acute respiratory disease marked by high fever and coughing)

40-49:

Anaemia (lack of blood)
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Muscular weakness (muscle weakness)
White blood cell count decreased

50-59:

Erythema (redness of the skin)
Pruritus (severe itching of the skin)
Aplasia (defective development or congenital absence of an organ or tissue)
Bacteraemia (presence of bacteria in the blood)
Toxic skin eruption (skin breakdown due to toxic substance)

60+:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
Dehydration (dryness resulting from the removal of water)
Diarrhoea
Sepsis (a severe blood infection that can lead to organ failure and death)
Vomiting
Bone marrow failure
Oral intake reduced
Septic shock (shock due to blood infection)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 25.00%
Septic Shock (shock due to blood infection): 5 people, 20.83%
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 4 people, 16.67%
Insomnia (sleeplessness): 3 people, 12.50%
Breast Cancer: 3 people, 12.50%
Stomatitis (inflammation of mucous membrane of mouth): 2 people, 8.33%
Oropharyngeal Candidiasis (fungal infection of oropharynx): 2 people, 8.33%
Gastric Ulcer (stomach ulcer): 2 people, 8.33%
Cough: 2 people, 8.33%
Bacteraemia (presence of bacteria in the blood): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tazidime and Emend?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously